Twist Bioscience Corporation
TWST
$29.70
-$0.16-0.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.14M | 20.39M | -39.33M | -31.59M | -34.66M |
| Total Depreciation and Amortization | 3.10M | 6.07M | 6.40M | 6.38M | 4.06M |
| Total Amortization of Deferred Charges | 2.90M | -- | -- | -- | 2.60M |
| Total Other Non-Cash Items | 16.30M | -31.64M | 21.16M | 11.97M | 13.82M |
| Change in Net Operating Assets | -6.98M | 3.78M | -1.22M | -8.19M | -1.14M |
| Cash from Operations | -11.81M | -1.40M | -12.99M | -21.43M | -15.32M |
| Capital Expenditure | -12.43M | -9.17M | -4.14M | -2.27M | -2.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 0.00 | 2.50M | -- | -- | -- |
| Other Investing Activities | 24.00K | -2.73M | 2.72M | 732.00K | 717.00K |
| Cash from Investing | -12.40M | -9.40M | -1.43M | -1.54M | -1.29M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.58M | 1.83M | 3.20M | 2.95M | 3.64M |
| Repurchase of Common Stock | -2.00K | -3.00K | -5.00K | -6.00K | -8.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 15.00M | -- |
| Cash from Financing | 5.57M | 1.83M | 3.20M | 17.94M | 3.63M |
| Foreign Exchange rate Adjustments | 163.00K | -71.00K | 104.00K | -53.00K | 73.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.48M | -9.04M | -11.11M | -5.07M | -12.91M |